全文获取类型
收费全文 | 18231篇 |
免费 | 1404篇 |
国内免费 | 52篇 |
专业分类
耳鼻咽喉 | 98篇 |
儿科学 | 564篇 |
妇产科学 | 531篇 |
基础医学 | 2491篇 |
口腔科学 | 322篇 |
临床医学 | 2584篇 |
内科学 | 3331篇 |
皮肤病学 | 385篇 |
神经病学 | 1803篇 |
特种医学 | 350篇 |
外科学 | 1608篇 |
综合类 | 176篇 |
一般理论 | 38篇 |
预防医学 | 2367篇 |
眼科学 | 424篇 |
药学 | 1345篇 |
中国医学 | 43篇 |
肿瘤学 | 1227篇 |
出版年
2024年 | 28篇 |
2023年 | 223篇 |
2022年 | 330篇 |
2021年 | 675篇 |
2020年 | 438篇 |
2019年 | 628篇 |
2018年 | 671篇 |
2017年 | 495篇 |
2016年 | 552篇 |
2015年 | 572篇 |
2014年 | 744篇 |
2013年 | 1055篇 |
2012年 | 1493篇 |
2011年 | 1472篇 |
2010年 | 829篇 |
2009年 | 675篇 |
2008年 | 1130篇 |
2007年 | 1156篇 |
2006年 | 1057篇 |
2005年 | 1050篇 |
2004年 | 922篇 |
2003年 | 878篇 |
2002年 | 733篇 |
2001年 | 103篇 |
2000年 | 72篇 |
1999年 | 95篇 |
1998年 | 145篇 |
1997年 | 125篇 |
1996年 | 111篇 |
1995年 | 95篇 |
1994年 | 83篇 |
1993年 | 94篇 |
1992年 | 54篇 |
1991年 | 49篇 |
1990年 | 39篇 |
1989年 | 30篇 |
1988年 | 41篇 |
1987年 | 41篇 |
1986年 | 34篇 |
1985年 | 37篇 |
1984年 | 46篇 |
1983年 | 44篇 |
1982年 | 48篇 |
1981年 | 45篇 |
1980年 | 53篇 |
1979年 | 22篇 |
1978年 | 32篇 |
1977年 | 29篇 |
1974年 | 20篇 |
1973年 | 23篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
991.
The fetal and neonatal brain protein neuronatin protects PC12 cells against certain types of toxic insult 总被引:2,自引:0,他引:2
Zheng S Chou AH Jimenez AL Khodadadi O Son S Melega WP Howard BD 《Brain research. Developmental brain research》2002,136(2):101-110
The protein neuronatin is expressed in the nervous system of the fetus and neonate at a much higher level than in the adult. Its function is unknown. As a result of variable splicing, neuronatin mRNA exists in two forms, alpha and beta. Wild type PC12 cells express neuronatin-alpha. We have isolated a PC12 variant, called 1.9, that retains many of the neuron-like properties of wild type PC12 cells, but it does not express neuronatin and it exhibits markedly increased sensitivity to the toxic effects of nigericin, rotenone and valinomycin. Pretreatment of the 1.9 cells with alpha-methyltyrosine, which inhibits dopamine synthesis, had little effect on the cells' sensitivity to nigericin, rotenone or valinomycin indicating that dopamine-induced oxidative stress was not involved in the toxicity of these compounds. However, flattened cell subvariants of the 1.9 cells, which do not have any neuron-specific characteristics, did not exhibit increased sensitivity to nigericin indicating that some neuronal characteristic of the 1.9 cells contributed to the toxicity of nigericin. After the neuronatin-beta gene was transfected into and expressed in the 1.9 cells, they regained wild type PC12 levels of resistance to nigericin, rotenone and valinomycin. These studies suggest that the function of neuronatin during development could be to protect developing cells from toxic insult occurring during that period. 相似文献
992.
Tan J Town T Abdullah L Wu Y Placzek A Small B Kroeger J Crawford F Richards D Mullan M 《Journal of neuroimmunology》2002,132(1-2):164-172
Aging represents the greatest risk for development of Alzheimer's disease (AD), and changes in peripheral immune cell phenotypes have been found to be associated with aging. Using flow cytometry, we measured the relative expression levels of CD45 isoforms, a marker of nai;ve versus memory CD4+ T cell status, on isolated CD4+ T lymphocytes from patients with a clinical diagnosis of probable Alzheimer's disease, normal elderly, cognitively abnormal elderly, and patients with clinically diagnosed other forms of dementia. Data show significantly lower levels of CD45RA, and an increase in the CD45RO/CD45RA ratio, on CD4+ T cells in patients diagnosed with probable Alzheimer's disease (n=46) and in cognitively abnormal individuals (n=37) compared to age-matched normal participants (n=90). Patients diagnosed with other forms of dementia (n=19) did not significantly differ from normal individuals. Both CD45RA and the CD45RO/CD45RA ratio had higher positive and negative predictive values and were more sensitive biomarkers of probable AD than the apolipoprotein E epsilon 4 allele, and had greater predictive ability for probable AD by regression analyses. Additionally, a testing strategy employing apolipoprotein E genotyping and CD45RA or the CD45RO/CD45RA ratio revealed increased sensitivity, positive and negative predictive values, and predictive ability over the apolipoprotein E epsilon 4 allele. These data show altered peripheral immunity in AD patients, and raise the possibility that a testing strategy using CD45 isoform alteration on CD4+ T cells and apolipoprotein E genotype may be clinically valuable for diagnosing probable AD. 相似文献
993.
994.
995.
Harrap SB Zammit KS Wong ZY Williams FM Bahlo M Tonkin AM Anderson ST 《Arteriosclerosis, thrombosis, and vascular biology》2002,22(5):874-878
A positive family history is a recognized cardiovascular risk factor, and genome-wide scans may reveal susceptibility loci for coronary artery disease. The acute coronary syndrome, consisting of myocardial infarction and unstable angina, is the most important manifestation of coronary disease and is characterized by atherosclerotic plaque disruption and coronary thrombosis. From approximately 6000 hospital admissions to cardiology units, we identified affected sibling pairs (n=61) who had documented acute coronary syndrome before the age of 70 years. A 10-cM resolution genetic map and MAPMAKER/SIBS were used for genome-wide linkage analysis. One locus on chromosome 2q36-q37.3 showed linkage with a lod score of 2.63 (P<0.0001). Separate multipoint fine-mapping of this locus with independent markers replicated the linkage results (lod 2.64). Two other regions on chromosomes 3q26-q27 and 20q11-q13 showed lod scores in excess of 1.5 (P<0.005). This genome scan in acute coronary syndrome suggests 1 locus that encompasses the gene encoding the insulin receptor substrate-1 gene. Two other potential loci were identified. These data imply that a limited number of potent susceptibility genes exist for the acute coronary syndrome. Such genes are likely to be relevant to the combined processes of atherosclerosis, plaque instability, and coronary thrombosis. 相似文献
996.
Water movements, of both abiotic and biotic origin, provide a wealth of information of direct relevance to the guidance of prey capture behavior. To gather hydrodynamic information, fish have sensors of two basic types: those scattered over the surface of the body known as superficial neuromasts and similar sensors embedded in subdermal lateral line canals. Recently, the anatomical dichotomy between superficial and canal neuromasts has been matched by demonstrations of a corresponding functional dichotomy. Prey detection and localization are evidently mediated by canal neuromasts, whereas superficial neuromasts are more sensitive to water flows over the surface of the fish and participate in the orientation to water currents, a behavior known as rheotaxis. However, rheotaxis in combination with chemosensory inputs can also guide fish to their prey. Thus there is evidence that both lateral line sub-modalities either alone or in concert with other senses play a role in prey capture. Are there circumstances where prey capture requires integration of information from both lateral line sub- modalities? Recent evidence shows that fish are capable of tracking other fish on the basis of the hydrodynamic trails left behind by their swimming motion. Pharmacological and physical ablation of lateral line end organs shows that indeed integration of information from both sub-modalities is required for the complex hydrodynamic task of natural prey capture in the dark. Furthermore, these experiments provide an excellent demonstration of the integration of hydrodynamic, chemosensory, tactile and visual information for the multimodal guidance of prey capture behavior. 相似文献
997.
Birley H Clark F Sparks R 《International journal of STD & AIDS》2002,13(9):647; author reply 647-647; author reply 648
998.
Gregoratos G Abrams J Epstein AE Freedman RA Hayes DL Hlatky MA Kerber RE Naccarelli GV Schoenfeld MH Silka MJ Winters SL Gibbons RI Antman EM Alpert JS Hiratzka LF Faxon DP Jacobs AK Fuster V Smith SC;American College of Cardiology/American Heart Association Task Force on Practice Guidelines American College of Cardiology/American Heart Association/North American Society for Pacing Electrophysiology Committee 《Journal of cardiovascular electrophysiology》2002,13(11):1183-1199
999.
OBJECTIVE: To prospectively assess bone density and the factors determining the rate of bone loss over a 10-year period of postmenopausal life. DESIGN: Prospective, observational study. METHODS: One hundred and four normal White postmenopausal women, baseline mean age 59 years (range 47-71 years) completed the study (mean duration of follow-up 10.2 years, range 9.4-10.6 years). None had diseases or were taking medications affecting bone metabolism at entry to the study. Information was collected on medical, fracture and smoking history, alcohol use, dietary calcium intake and physical activity. Body composition and bone density were measured by dual-energy X-ray absorptiometry at baseline and at 10 years. Biochemical, haematological and hormonal analyses were performed. RESULTS: Twenty-four percent of the women started hormone replacement therapy (HRT) during the study period; most of these remained on therapy at follow-up. The mean duration of therapy was 6.6 years (range 2.8-10.4 years). The use of HRT was associated with significant gains in bone density (total body + 3.0%, trochanter + 4.2%, Ward's triangle + 4.4%, spine + 10.5%) and a significant reduction in vertebral fracture risk [standardized risk ratio compared with non-HRT users 0.42 (confidence interval 0.18-0.83)]. HRT use was not associated with greater weight gain than that occurring in other members of the cohort. The baseline and follow-up bone densities in the non-HRT users were highly correlated (0.82 < or = r < or = 0.91, P < or = 0.0001) and baseline bone density accounted for the majority of the variance in the 10-year results. Multivariate analyses showed that the independent correlates of rate of change of bone density were weight and fat mass (both baseline values and changes during follow-up), time after menopause, sex hormone concentrations, urinary calcium loss, PTH levels and haemoglobin concentration (which may reflect nutrition and health). CONCLUSIONS: Bone density is highly predictable over an extended period of time in normal postmenopausal women. Maintenance of body weight and good health reduce bone loss. HRT is effective for treating osteoporosis, with improvement in bone density and reduction in vertebral fractures. Good compliance with HRT long-term is achievable. These findings are relevant to deciding the frequency of bone density measurement, and in advising women regarding prevention and treatment of postmenopausal bone loss. 相似文献
1000.